Free Trial

MariMed Q4 2024 Earnings Report

MariMed logo
$0.09 -0.01 (-6.00%)
As of 04/2/2025 03:58 PM Eastern

MariMed EPS Results

Actual EPS
-$0.01
Consensus EPS
-$0.01
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

MariMed Revenue Results

Actual Revenue
$39.00 million
Expected Revenue
$42.00 million
Beat/Miss
Missed by -$3.00 million
YoY Revenue Growth
N/A

MariMed Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Remove Ads

MariMed Earnings Headlines

Marimed launches Nature’s Heritage Flower in Illinois
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
MariMed Launches Nature's Heritage™ Flower in Illinois
MariMed Inc. (OTCMKTS:MRMD) Short Interest Down 63.1% in March
See More MariMed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MariMed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MariMed and other key companies, straight to your email.

About MariMed

MariMed (OTCMKTS:MRMD) engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

View MariMed Profile

More Earnings Resources from MarketBeat